EHA Takes Early Action on EU’s Forthcoming Biotech Act: Biotechnology Wonders 2026
The European Hematology Association (EHA) recently shared a post on X:
”The EU is developing new legislation that will impact hematology – the Biotech Act.
EHA ensures that hematologists are represented in this process.”
Read the preliminary recommendations for a Biotech Act here.
In 2024, the European Commission launched preparatory work on a landmark piece of legislation—the Biotech Act—set to be formally proposed in 2026.
Aimed at streamlining the development and market access of biotech products, the regulation also seeks to uphold high safety standards while bolstering the competitiveness and scale of the EU’s biotechnology sector.
Although the legislative text is still in the works, key stakeholders are already mobilizing.
The European Hematology Association (EHA) has actively stepped in to ensure the voice of hematologists is heard from the outset.
Through early advocacy and strategic engagement, EHA is positioning the hematology community to help shape a regulatory environment that supports innovation while protecting patient safety.
As the Biotech Act progresses, EHA remains committed to representing the field throughout every phase of the EU legislative process.
Latest updates in the World of Hematology featured in Hemostasis Today.
-
Mar 2, 2026, 17:22Hematologists and Oncologists Recognize Their Role in Specialized VA Care Despite Ongoing Knowledge Gaps – JTH
-
Mar 2, 2026, 17:04Fernando Corrales-Medina: An Evidence-Based Platform Promoting Early Recognition and Evaluation of VWD
-
Mar 2, 2026, 16:56Mbunya S. Misiani: Changing the Narrative on Bleeding Disorders Across Africa
-
Mar 2, 2026, 16:51Ofoke Chiamaka: Rehabilitation Is Not Just Muscle Training, It Is Brain Retraining
-
Mar 2, 2026, 16:41Paul Bolaji: Beyond Acute Stroke Care – Independent Integrated Living After Stroke
-
Mar 2, 2026, 16:37Gianluca Franceschini: Precision Medicine Is Only Truly Effective If It Is Inclusive
-
Mar 2, 2026, 16:34Maha Othman: Calling a Guest Editor for Current Opinion in Hematology
-
Mar 2, 2026, 16:30Tareq Abadl: Erythropoiesis – The Cellular Engineering Behind Oxygen Delivery
-
Mar 2, 2026, 16:28Tagreed Alkaltham: Blood Management in Times of Crisis